Prostate Cancer: UK Treatment Pathway - Introduction
Online Course
•
Greater Manchester Cancer Academy
About the CPD course
This Module introduces and establishes the benefits of a 28-day diagnostic prostate cancer pathway. The content explores prostate cancer incidence rate; prognosis; morbidity and mortality. This encompasses some of the key global and UK statistics for prostate cancer; highlighting the high prostate cancer incidence rate; with insights into the natural history of the disease and some of the risk factors for developing prostate cancer. The need for early diagnosis to give patients timely access to appropriate treatment as they start their disease management journey is highlighted. This resource aims to inform and support the optimisation of patient care.
We’re ‘buzzing’ to be sharing with you the latest education venture at Greater Manchester Cancer Alliance. The Greater Manchester Cancer Academy – the hive of cancer education – will support the development of a sustainable lifelong learning model for cancer care across all care settings. We want to ensure that our workforce is equipped with the skills and tools necessary to delivery the best patient care whilst supporting the delivery of the NHS People Plan and the Long Term Plan ambitions for cancer services. The Academy will help to reduce inequity around accessing cancer education and provides a mechanism to standardise training, education and career frameworks for our current and future non-medical workforce.
